Inmune Bio (INMB US)

Health Care • United States

INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00